---
title: "Allmed Medical Products Co., Ltd (002950.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002950.SZ.md"
symbol: "002950.SZ"
name: "Allmed Medical Products Co., Ltd"
industry: "Health Care Supplies"
datetime: "2026-05-19T22:49:38.600Z"
locales:
  - [en](https://longbridge.com/en/quote/002950.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002950.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002950.SZ.md)
---

# Allmed Medical Products Co., Ltd (002950.SZ)

## Company Overview

Allmed Medical Products Co.,Ltd manufactures and sells wound care and nursing material products in China. The company’s traditional wound care products include non-woven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton-filled exodontia sponges, packing strips, ribbon gauze, cotton-tipped applicators, elastic net bandages, nose bandages, instrument covers, impregnated gauze dressings, adhesive dressings and tapes, wound bandages, kits, and precut gamgee. Its advanced wound care products consist of hydrocolloid dressings, hydrocolloid bandages, blister dressings, silicone foam dressings, superabsorbent dressings, silicone scar patches, and alginate dressings. OR consumables include x-ray woven gauze/nonwoven gauze swabs and balls, neuro and laparotomy sponges, OR towels, and disposable towel drapes.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.allmed-china.com/;https://www.allmed.cn](https://www.allmed-china.com/;https://www.allmed.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: B (0.34)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 7 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 14.09% |  |
| Net Profit YoY | -24.90% |  |
| P/B Ratio | 1.92 |  |
| Dividend Ratio | 0.52% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 7104779586.65 |  |
| Revenue | 3805369715.20 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.52% | B |
| Profit Margin | 7.12% | B |
| Gross Margin | 32.67% | C |
| Revenue YoY | 14.09% | B |
| Net Profit YoY | -24.90% | D |
| Total Assets YoY | 12.93% | B |
| Net Assets YoY | 5.54% | C |
| Cash Flow Margin | 211.04% | B |
| OCF YoY | 14.09% | B |
| Turnover | 0.68 | B |
| Gearing Ratio | 36.96% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Allmed Medical Products Co., Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "14.09%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-24.90%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.92",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.52%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "7104779586.65",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3805369715.20",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.52%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "7.12%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "32.67%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "14.09%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-24.90%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.93%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.54%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "211.04%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "14.09%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.68",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "36.96%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 26.26 | 10/40 | 17.01 | 16.07 | 15.35 |
| PB | 1.93 | 16/40 | 2.01 | 1.85 | 1.67 |
| PS (TTM) | 1.87 | 4/40 | 2.15 | 1.94 | 1.75 |
| Dividend Yield | 0.52% | 29/40 | 0.61% | 0.53% | 0.47% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/002950.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/002950.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/002950.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/002950.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**